More Results
    Please select a product

    Are you sure you want to change languages?

    The page you are visiting uses a different locale than your saved profile. Do you want to change your locale?

    Cookies are required to enter the site.

    When entering the site and if cookies are prevented from being saved, a message must be displayed in a popup message box informing the user that their local browser settings are preventing cookies from being saved and that cookies are required for the site to work. Exact text to be provided for UAT. On OK click of the message, the user should be redirected to the global landing page (currently ssga.com).

    Okay

    SPDR® S&P® Pharmaceuticals ETF XPH

    Important Risk Disclosure

    NAV

    NAV

    The market value of a mutual fund's or ETFs total assets, minus liabilities, divided by the number of shares outstanding.

    $42.48

    as of Sep 24 2020

    Base Currency

    USD

    Assets Under Management

    $216.67 M

    as of Sep 24 2020

    Gross Expense Ratio

    Gross Expense Ratio

    The fund's total annual operating expense ratio. It is gross of any fee waivers or expense reimbursements. It can be found in the fund's most recent prospectus.

    0.35%

    Quick Links

    Key Features

    Key Features

    • The SPDR® S&P® Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P® Pharmaceuticals Select Industry® Index (the "Index")
    • Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industry
    • Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks
    • Allows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing

    About this Benchmark

    About this Benchmark

    The S&P Pharmaceuticals Select Industry Index (the "Index") represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the Pharmaceuticals sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the "Select Industry Indices"), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ("GICS").

    Fund Information as of Sep 24 2020

    Fund Information as of Sep 24 2020
    Benchmark Inception Date Options Available Gross Expense Ratio

    Gross Expense Ratio

    The fund's total annual operating expense ratio. It is gross of any fee waivers or expense reimbursements. It can be found in the fund's most recent prospectus.

    		 Base Currency Investment Manager Management Team
    S&P Pharmaceuticals Select Industry Index Jun 16 2006 Yes 0.35% USD SSGA Funds Management, Inc. Global Equity Beta Solutions
    Benchmark S&P Pharmaceuticals Select Industry Index
    Inception Date Jun 16 2006
    Options Available Yes
    Gross Expense Ratio

    Gross Expense Ratio

    The fund's total annual operating expense ratio. It is gross of any fee waivers or expense reimbursements. It can be found in the fund's most recent prospectus.

    		 0.35%
    Base Currency USD
    Investment Manager SSGA Funds Management, Inc.
    Management Team Global Equity Beta Solutions
    Distributor Distribution Frequency
    State Street Global Advisors Funds Distributors, LLC Quarterly
    Distributor State Street Global Advisors Funds Distributors, LLC
    Distribution Frequency Quarterly

    Listing Information as of Sep 24 2020

    Listing Information as of Sep 24 2020
    Exchange Listing Date Trading Currency Ticker CUSIP ISIN
    NYSE ARCA EXCHANGE Jun 23 2006 USD XPH 78464A722 US78464A7220
    Exchange NYSE ARCA EXCHANGE
    Listing Date Jun 23 2006
    Trading Currency USD
    Ticker XPH
    CUSIP 78464A722
    ISIN US78464A7220

    Fund Characteristics as of Sep 24 2020

    Fund Characteristics as of Sep 24 2020
    Est. 3-5 Year EPS Growth

    Estimated 3-5 Year EPS Growth

    Based on the underlying holdings of the fund. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate.

    		 Number of Holdings Price/Book Ratio

    Price/Book Ratio

    The weighted harmonic average of closing market price divided by the most recent reported book value for each security in the fund's portfolio as calculated for the last twelve months.

    		 Price/Earnings Ratio FY1

    Price/Earnings Ratio FY1

    The weighted harmonic average of current share price divided by the forecasted one year earnings per share for each security in the fund. Negative and positive outliers are included in the calculation.

    		 Weighted Average Market Cap
    12.99% 42 3.00 10.71 $55,277.59 M
    Est. 3-5 Year EPS Growth

    Estimated 3-5 Year EPS Growth

    Based on the underlying holdings of the fund. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate.

    		 12.99%
    Number of Holdings 42
    Price/Book Ratio

    Price/Book Ratio

    The weighted harmonic average of closing market price divided by the most recent reported book value for each security in the fund's portfolio as calculated for the last twelve months.

    		 3.00
    Price/Earnings Ratio FY1

    Price/Earnings Ratio FY1

    The weighted harmonic average of current share price divided by the forecasted one year earnings per share for each security in the fund. Negative and positive outliers are included in the calculation.

    		 10.71
    Weighted Average Market Cap $55,277.59 M

    Index Characteristics as of Sep 24 2020

    Index Characteristics as of Sep 24 2020
    Est. 3-5 Year EPS Growth Number of Holdings Price/Cash Flow Price/Earnings Price/Earnings Ratio FY1
    13.00% 42 9.81 18.70 10.71
    Est. 3-5 Year EPS Growth 13.00%
    Number of Holdings 42
    Price/Cash Flow 9.81
    Price/Earnings 18.70
    Price/Earnings Ratio FY1 10.71

    Index Statistics as of Sep 24 2020

    Index Statistics as of Sep 24 2020

    Average Size
    Size Range
    Weighted Average Market Cap Mean Median Largest Smallest
    $55,279.14 M $29,651.63 M $1,604.11 M $380,825.97 M $387.46 M
    Weighted Average Market Cap $55,279.14 M
    Average Size
    Mean $29,651.63 M
    Median $1,604.11 M
    Size Range
    Largest $380,825.97 M
    Smallest $387.46 M

    Yields as of Sep 24 2020

    Yields as of Sep 24 2020
    30 Day SEC Yield

    30 Day SEC Yield

    (Also known as Standardized Yield) An annualized yield that is calculated by dividing the net investment income earned by the fund over the most recent 30-day period by the current maximum offering price.

    		 30 Day SEC Yield (Unsubsidized)

    30 Day SEC Yield (Unsubsidized)

    An annualized yield that is calculated by dividing the net investment income earned by the fund over the most recent 30-day period by the current maximum offering price that does not account for expense ratio waivers.

    		 Fund Dividend Yield

    Fund Dividend Yield

    The sum of the most recent 12 dividends within the past 365 days divided by Net Asset Value per share, expressed as a percentage.

    		 Index Dividend Yield

    Index Dividend Yield

    The weighted average of the underlyings' indicated annual dividend divided by price, expressed as a percentage.
    0.45% - 0.62% 0.79%
    30 Day SEC Yield

    30 Day SEC Yield

    (Also known as Standardized Yield) An annualized yield that is calculated by dividing the net investment income earned by the fund over the most recent 30-day period by the current maximum offering price.

    		 0.45%
    30 Day SEC Yield (Unsubsidized)

    30 Day SEC Yield (Unsubsidized)

    An annualized yield that is calculated by dividing the net investment income earned by the fund over the most recent 30-day period by the current maximum offering price that does not account for expense ratio waivers.

    		 -
    Fund Dividend Yield

    Fund Dividend Yield

    The sum of the most recent 12 dividends within the past 365 days divided by Net Asset Value per share, expressed as a percentage.

    		 0.62%
    Index Dividend Yield

    Index Dividend Yield

    The weighted average of the underlyings' indicated annual dividend divided by price, expressed as a percentage.

    		 0.79%

    Fund Market Price as of Sep 24 2020

    Fund Market Price as of Sep 24 2020
    Bid/Ask

    Bid/Ask Mid Point

    (Also known as Mid Price) The price between the best price of the sellers for a trading unit of a given security and the best price of the buyer of a trading unit of a given security.

    		 Closing Price

    Closing Price

    Market Price of last reported trade on the exchange.

    		 Day High Day Low Exchange Volume (Shares)

    Exchange Volume (shares)

    Represents the volume of shares traded on the ETF's primary exchange throughout the previous business day.

    		 Premium/Discount

    Premium/Discount to NAV

    Shows the comparison of the daily net asset value (NAV) and the Midpoint of the closing bid/ask for each of the funds calculated as ((4PM Bid/Ask - Closing NAV) / Closing NAV * 100)
    $42.48 $42.46 $43.13 $42.26 20,616 -0.02%
    Bid/Ask

    Bid/Ask Mid Point

    (Also known as Mid Price) The price between the best price of the sellers for a trading unit of a given security and the best price of the buyer of a trading unit of a given security.

    		 $42.48
    Closing Price

    Closing Price

    Market Price of last reported trade on the exchange.

    		 $42.46
    Day High $43.13
    Day Low $42.26
    Exchange Volume (Shares)

    Exchange Volume (shares)

    Represents the volume of shares traded on the ETF's primary exchange throughout the previous business day.

    		 20,616
    Premium/Discount

    Premium/Discount to NAV

    Shows the comparison of the daily net asset value (NAV) and the Midpoint of the closing bid/ask for each of the funds calculated as ((4PM Bid/Ask - Closing NAV) / Closing NAV * 100)

    		 -0.02%

    Premium Discount to Nav

    Quarter
      x axis: # of days
      y axis: # Premium/Discount percentage
      Fund Data

      The above information is provided to show the comparison of the daily net asset value (NAV) and the Midpoint of the closing bid/ask for each of the funds.

      Before investing, consider the funds' investment objectives, risks, charges and expenses. To obtain a prospectus or summary prospectus which contains this and other information, call 1-866-787-2257 download a prospectus or summary prospectus now, or talk to your financial advisor. Read it carefully before investing.

      Fund Net Cash Amount as of Sep 24 2020

      Fund Net Cash Amount as of Sep 24 2020
      Net Cash Amount
      $27,004.81
      Net Cash Amount $27,004.81

      Fund Net Asset Value as of Sep 24 2020

      Fund Net Asset Value as of Sep 24 2020
      NAV

      NAV

      The market value of a mutual fund's or ETFs total assets, minus liabilities, divided by the number of shares outstanding.

      		 Shares Outstanding Assets Under Management
      $42.48 5.10 M $216.67 M
      NAV

      NAV

      The market value of a mutual fund's or ETFs total assets, minus liabilities, divided by the number of shares outstanding.

      		 $42.48
      Shares Outstanding 5.10 M
      Assets Under Management $216.67 M
      Most Recent NAV / NAV History

      Fund Performance

      Fund Performance

      • Fund Inception Date: Jun 16 2006
      • Performance Inception Date: Jun 19 2006
      Performance
      Month End Quarter End

      as of Aug 31 2020

      as of Jun 30 2020

      As Of 1 Month QTD YTD 1 Year 3 Year 5 Year 10 Year Since Inception
      Jun 19 2006
      Fund Before Tax
      NAV Aug 31 2020 3.82% 2.74% -2.88% 25.76% 1.74% -3.44% 10.59% 9.56%
      Market Value Aug 31 2020 3.81% 2.76% -2.84% 25.87% 1.76% -3.43% 10.58% 9.56%
      S&P Pharmaceuticals Select Industry Index Aug 31 2020 3.85% 2.80% -2.85% 25.95% 1.89% -3.29% 10.78% 9.75%
      Fund After Tax
      Return after Taxes on Distributions Aug 31 2020 3.82% 2.74% -3.02% 25.46% 1.56% -4.10% 9.87% 8.98%
      Return after Taxes on Distributions and Sale of Fund Shares Aug 31 2020 2.26% 1.62% -1.72% 15.31% 1.30% -2.78% 8.56% 7.90%
      S&P Pharmaceuticals Select Industry Index Aug 31 2020 3.85% 2.80% -2.85% 25.95% 1.89% -3.29% 10.78% 9.75%
      As Of 1 Month QTD YTD 1 Year 3 Year 5 Year 10 Year Since Inception
      Jun 19 2006
      Fund Before Tax
      NAV Jun 30 2020 -0.12% 19.56% -5.47% 9.18% 0.73% -5.36% 10.65% 9.47%
      Market Value Jun 30 2020 -0.05% 19.54% -5.45% 9.16% 0.73% -5.37% 10.64% 9.46%
      S&P Pharmaceuticals Select Industry Index Jun 30 2020 -0.09% 19.67% -5.49% 9.27% 0.86% -5.22% 10.85% 9.66%
      Fund After Tax
      Return after Taxes on Distributions Jun 30 2020 -0.18% 19.49% -5.61% 8.92% 0.54% -5.99% 9.93% 8.89%
      Return after Taxes on Distributions and Sale of Fund Shares Jun 30 2020 -0.07% 11.58% -3.25% 5.49% 0.52% -4.16% 8.63% 7.82%
      S&P Pharmaceuticals Select Industry Index Jun 30 2020 -0.09% 19.67% -5.49% 9.27% 0.86% -5.22% 10.85% 9.66%

      Performance quoted represents past performance, which is no guarantee of future results. Investment return and principal value will fluctuate, so you may have a gain or loss when shares are sold. Current performance may be higher or lower than that quoted. Performance of an index is not illustrative of any particular investment.  It is not possible to invest directly in an index.

      Performance returns for periods of less than one year are not annualized.  Performance is shown net of fees.

      The market price used to calculate the Market Value return is the midpoint between the highest bid and the lowest offer on the exchange on which the shares of the Fund are listed for trading, as of the time that the Fund's NAV is calculated. If you trade your shares at another time, your return may differ.

      Gross Expense Ratio: 0.35%

      Top Holdings

      Subject to change.

      Top Holdings

      Subject to change.

      Fund Top Holdingsas of Sep 24 2020
      Index Top Holdingsas of Sep 24 2020

      Fund Top Holdings as of Sep 24 2020

      Name Shares Held Total Mkt Cap M Weight
      Horizon Therapeutics Public Limited Company 139,970 $15,925.32 4.87%
      Royalty Pharma Plc Class A 256,055 $14,720.13 4.75%
      Reata Pharmaceuticals Inc. Class A 97,541 $2,934.18 4.63%
      Jazz Pharmaceuticals Plc 72,175 $7,656.06 4.60%
      Eli Lilly and Company 66,672 $142,332.36 4.58%
      Zoetis Inc. Class A 62,258 $75,063.36 4.54%
      Pfizer Inc. 273,731 $198,714.02 4.52%
      Bristol-Myers Squibb Company 167,375 $131,291.70 4.50%
      Merck & Co. Inc. 116,873 $210,306.40 4.49%
      Johnson & Johnson 66,812 $380,890.56 4.46%
      Download All Holdings: Daily

      Index Top Holdings as of Sep 24 2020

      Name Total Mkt Cap M Weight
      Horizon Therapeutics Public Limited Company $15,925.32 4.87%
      Royalty Pharma Plc Class A $14,720.13 4.76%
      Reata Pharmaceuticals Inc. Class A $2,934.18 4.63%
      Jazz Pharmaceuticals Plc $7,656.06 4.60%
      Eli Lilly and Company $142,332.36 4.58%
      Zoetis Inc. Class A $75,063.36 4.54%
      Pfizer Inc. $198,714.02 4.52%
      Bristol-Myers Squibb Company $131,291.70 4.50%
      Merck & Co. Inc. $210,306.40 4.49%
      Johnson & Johnson $380,890.56 4.46%

      Sub-Industry Allocation

      Sub-Industry Allocation

      Fund Sub-Industry Allocation as of Sep 24 2020

      Sector Weight
      Pharmaceuticals 100.00%

      Index Sub-Industry Allocation as of Sep 24 2020

      Sector Weight
      Pharmaceuticals 100.00%
      Fund Documents
      Tax Documents
      Information & Schedules

      Purchase Information

      Purchase Information

      Buying and Selling ETFs

      ETFs are flexible and easy to trade. Investors buy and sell them like stocks, typically through a brokerage account. Investors can also employ traditional stock trading techniques; including stop orders, limit orders, margin purchases, and short sales using ETFs. They are listed on major US Stock Exchanges.

      ETFs are subject to risk similar to those of stocks including those regarding short-selling and margin account maintenance.

      Ordinary brokerage commissions apply.

      Fund Footnotes

      In general, ETFs can be expected to move up or down in value with the value of the applicable index. Although ETF shares may be bought and sold on the exchange through any brokerage account, ETF shares are not individually redeemable from the Fund. Investors may acquire ETFs and tender them for redemption through the Fund in Creation Unit Aggregations only. Please see the prospectus for more details.

      After-tax returns are calculated based on NAV using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on the investor's tax situation and may differ from those shown. The after-tax returns shown are not relevant to investors who hold their fund shares through tax-deferred arrangements such as 401(k) plans or individual retirement accounts.

      Unless otherwise noted all information contained herein is that of the SPDR S&P Pharmaceuticals ETF.

      Performance of an index is not illustrative of any particular investment. It is not possible to invest directly in an index.

      Holdings and sectors shown are as of the date indicated and are subject to change. This information should not be considered a recommendation to invest in a particular sector or to buy or sell any security shown. It is not known whether the sectors or securities shown will be profitable in the future.

      As with all stocks, you may be required to deposit more money or securities into your margin account if the equity, including the amount attributable to your ETF shares, declines.

      The S&P Select Industry Index series is designed to measure the performance of narrow GICS (Global Industry Classification S&Standard) sub-industries. The S&P Pharmaceuticals Select Industry Index is an equal-weighted index that draws constituents from the pharmaceuticals segment of the S&P TMI. Liquidity and market capitalization screens are applied to the index to ensure investability.

      Questions? Feel free to

      Content on this site is approved for Investment Professional use only.
       

      View More Information About Our Firm: FINRA's BrokerCheck
       

      ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.
       

      Standard & Poor's®, S&P® and SPDR® are registered trademarks of Standard & Poor's Financial Services LLC (S&P); Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC (Dow Jones); and these trademarks have been licensed for use by S&P Dow Jones Indices LLC (SPDJI) and sublicensed for certain purposes by State Street Corporation. State Street Corporation's financial products are not sponsored, endorsed, sold or promoted by SPDJI, Dow Jones, S&P, their respective affiliates and third party licensors and none of such parties make any representation regarding the advisability of investing in such product(s) nor do they have any liability in relation thereto, including for any errors, omissions, or interruptions of any index.
       

      Distributor: State Street Global Advisors Funds Distributors, LLC, member FINRA, SIPC,  an indirect wholly owned subsidiary of State Street Corporation. References to State Street may include State Street Corporation and its affiliates. Certain State Street affiliates provide services and receive fees from the SPDR ETFs. ALPS Distributors, Inc., member FINRA, is the distributor for DIA, MDY and SPY, all unit investment trusts. ALPS Portfolio Solutions Distributor, Inc., member FINRA, is the distributor for Select Sector SPDRs. ALPS Distributors, Inc. and ALPS Portfolio Solutions Distributor, Inc. are not affiliated with State Street Global Advisors Funds Distributors, LLC.
       

      THIS SITE IS INTENDED FOR QUALIFIED INVESTORS ONLY.
       

      No Offer/Local Restrictions
       

      Nothing contained in or on the Site should be construed as a solicitation of an offer to buy or offer, or recommendation, to acquire or dispose of any security, commodity, investment or to engage in any other transaction. SSGA Intermediary Business offers a number of products and services designed specifically for various categories of investors. Not all products will be available to all investors. The information provided on the Site is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation.
       

      All persons and entities accessing the Site do so on their own initiative and are responsible for compliance with applicable local laws and regulations. The Site is not directed to any person in any jurisdiction where the publication or availability of the Site is prohibited, by reason of that person's nationality, residence or otherwise. Persons under these restrictions must not access the Site.

      Information for Non-U.S. Investors:
       

      The products and services described on this web site are intended to be made available only to persons in the United States or as otherwise qualified and permissible under local law. The information on this web site is only for such persons. Nothing on this web site shall be considered a solicitation to buy or an offer to sell a security to any person in any jurisdiction where such offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction.
       

      Before investing, consider the funds' investment objectives, risks, charges and expenses. To obtain a prospectus or summary prospectus which contains this and other information, call 1-866-787-2257, download a prospectus or summary prospectus  now, or talk to your financial advisor. Read it carefully before investing.
       

      Not FDIC Insured * No Bank Guarantee * May Lose Value

      2732006.4.1.AM.INST

       

      Sitemap

      © 2020 %%State Street Corporation%%. All rights reserved.